Seoul National Universuty, Bundang Hospital
Seongnam-si, Gyonggido, South Korea
NCT Number: NCT04754451
The lidocaine patch is currently only permitted for post herpetic neuralgia but the investigators want to study its effectiveness in post operative pain after inguinal herniorrhaphy
Looking for future studies?
Notify Me19 year–80 year
All sexes
Interventional
Phase 4
Seongnam-si, Gyonggido, South Korea
After open unilateral inguinal herniorrhaphy, patients are randomly divided into group L and group P groups. Group L attaches two lidocaine patches for 12 hours, above and below the incision site. Group P attaches two placebo patches for 12 hours, above and below the incision site. Pain scores are recorded for 30 minutes, 2 hours, 24 hours, and 1 week after surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Attach two lidocaine patches for 12 hours, one above and below the incision site.
Other names: lidotopcaplasma
Time frame: 24 hours after the anesthesia finished.
VAS(visual analog scale) measurement for 24 hours after surgery(0-10) 0: no pain 10: severe pain
Time frame: 30 min after the anesthesia finished.
VAS(visual analog scale) measurement for 24 hours after surgery(0-10) 0: no pain 10: severe pain
Time frame: 2 hours after the anesthesia finished.
VAS(visual analog scale) measurement for 24 hours after surgery(0-10) 0: no pain 10: severe pain
Time frame: 24 hours after the anesthesia finished.
total amount of analgesics are measured for 24 hours after surgery.
BON WOOK KOO
Other
The Efficacy and Safety of 5% Lidocaine Patch for Postoperative Pain in Unilateral Inguinal Herniorrhaphy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07735884
Acute Pain, Femoral Fractures
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT07335159
Acute Pain, Agnosia
Tallahassee, Florida, United States
View Trial DetailsNCT07500454
Acute Pain, Neurologic Manifestations
Mexico City, Mexico
View Trial DetailsNCT05229055
Acute Pain, Neurologic Manifestations
Monastir, Tunisia
View Trial Details